Literature DB >> 11496958

Comparison of tissue concentrations after intramuscular and topical administration of ketoprofen.

I Tegeder1, J Lötsch, M Kinzig-Schippers, F Sörgel, G R Kelm, S T Meller, G Geisslinger.   

Abstract

PURPOSE: To assess whether topical ketoprofen, which has been reported to provide analgesic effects in clinical studies, reaches predictable tissue concentrations high enough to account for the reported analgesia. Intramuscular ketoprofen was used as positive control.
METHODS: Muscle and subcutaneous tissue concentrations were assessed by microdialysis. Plasma and tissue concentrations after intramuscular injection were described using a three-compartment population pharmacokinetic model. The prediction performance of the model was assessed by superimposing tissue concentrations of 12 subjects that did not participate in the present study.
RESULTS: Most dialysate concentrations after topical dosing of ketoprofen (100 mg) were below the quantification limit of 0.47 ng/ml. Plasma concentrations increased slowly and reached an apparent plateau of 7-40 ng/ml at 10-12h. No decline was observed up to 16 h. Tissue concentrations after intramuscular injection (100 mg) were about 10 times higher than those after topical dosing. Tissue concentrations measured in the majority of the 12 subjects that did not participate in the present study were found within the range of two-thirds of the predicted concentrations.
CONCLUSION: Predictable and cyclooxygenase-inhibiting concentrations of ketoprofen were achieved in subcutaneous and muscle tissue after intramuscular but not after topical dosing. Thus, the tissue concentrations of ketoprofen after topical administration can hardly explain the reported clinical efficacy of topical ketoprofen.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11496958     DOI: 10.1023/a:1010940428479

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  20 in total

1.  The effects of a newly developed nonsteroidal anti-inflammatory drug (M-5011) on arachidonic acid metabolism in rheumatoid synovial fibroblasts.

Authors:  K Tobetto; Y Yamamoto; M Kataoka; T Ando; K Sugimoto; M Himeno
Journal:  Jpn J Pharmacol       Date:  1997-12

Review 2.  Pharmacoeconomics of nonsteroidal anti-inflammatory drugs (NSAIDs).

Authors:  H A Wynne; M Campbell
Journal:  Pharmacoeconomics       Date:  1993-02       Impact factor: 4.981

3.  Stereoselective inhibition of rat brain cyclooxygenase by dexketoprofen.

Authors:  A Carabaza; F Cabré; A M García; E Rotllan; M L García; D Mauleón
Journal:  Chirality       Date:  1997       Impact factor: 2.437

Review 4.  Systematic review of outpatient services for chronic pain control.

Authors:  H J McQuay; R A Moore; C Eccleston; S Morley; A C Williams
Journal:  Health Technol Assess       Date:  1997       Impact factor: 4.014

5.  Non-steroidal anti-inflammatory drugs and elderly patients.

Authors:  D N Bateman; J G Kennedy
Journal:  BMJ       Date:  1995-04-01

6.  Stereoselective inhibition of inducible cyclooxygenase by chiral nonsteroidal antiinflammatory drugs.

Authors:  A Carabaza; F Cabré; E Rotllan; M Gómez; M Gutiérrez; M L García; D Mauleón
Journal:  J Clin Pharmacol       Date:  1996-06       Impact factor: 3.126

7.  Gentamicin concentrations in human subcutaneous tissue.

Authors:  H Lorentzen; F Kallehave; H J Kolmos; U Knigge; J Bülow; F Gottrup
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

8.  Pharmacokinetics of ketoprofen enantiomers after different doses of the racemate.

Authors:  G Geisslinger; S Menzel; K Wissel; K Brune
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

Review 9.  20 years' experience with ketoprofen.

Authors:  E M Veys
Journal:  Scand J Rheumatol Suppl       Date:  1991

10.  Safety of ketoprofen in the elderly: a prospective study on 20,000 patients.

Authors:  X Le Loet
Journal:  Scand J Rheumatol Suppl       Date:  1989
View more
  4 in total

1.  Iontophoresis driven concentrations of topically administered diclofenac in skeletal muscle and blood of healthy subjects.

Authors:  Richard Crevenna; Angela Burian; Zoe Oesterreicher; Edith Lackner; Walter Jäger; Gottfried Rezcicek; Mohammad Keilani; Markus Zeitlinger
Journal:  Eur J Clin Pharmacol       Date:  2015-08-14       Impact factor: 2.953

2.  A microdialysis study of topically applied diclofenac to healthy humans: Passive versus iontophoretic delivery.

Authors:  Birgit Falk Riecke; Else Marie Bartels; Søren Torp-Pedersen; Søren Ribel-Madsen; Henning Bliddal; Bente Danneskiold-Samsøe; Lars Arendt-Nielsen
Journal:  Results Pharma Sci       Date:  2011-11-04

3.  Randomized clinical comparisons of diclofenac concentration in the soft tissues and blood plasma between topical and oral applications.

Authors:  Shin Miyatake; Hiroki Ichiyama; Eiji Kondo; Kazunori Yasuda
Journal:  Br J Clin Pharmacol       Date:  2009-01       Impact factor: 4.335

4.  Which Analysis Approach Is Adequate to Leverage Clinical Microdialysis Data? A Quantitative Comparison to Investigate Exposure and Reponse Exemplified by Levofloxacin.

Authors:  David Busse; André Schaeftlein; Alexander Solms; Luis Ilia; Robin Michelet; Markus Zeitlinger; Wilhelm Huisinga; Charlotte Kloft
Journal:  Pharm Res       Date:  2021-03-15       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.